Zovighian Bernard J 4

What Happened

• Bernard J. Zovighian, CEO and Director of Edwards Lifesciences (EW), reported an open-market sale of 2,920.551 shares on 2026-07-27 at $83.93 per share, for total proceeds of $245,134.
• The Form 4 also shows two gift transactions (code G) of 319.65 shares each at $0.00 — one listed as disposed and one listed as acquired — which reflect transfers with no cash value.
• The primary transaction is a sale (often routine insider selling); the gifts do not involve cash consideration and are not itself a market sentiment signal.

Key Details

• Transaction date(s): 2026-07-27
• Sale: 2,920.551 shares at $83.93 — proceeds $245,134
• Gifts: 319.65 shares @ $0.00 (disposed) and 319.65 shares @ $0.00 (acquired); no cash exchanged
• Shares owned after the transactions: not specified in the provided filing excerpt
• Filing: Form 4 filed with accession 0001225208-26-006743 on 2026-07-27 (no late-filing indication in the supplied details)
• Remarks on the filing: "This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."

Context

• Open-market sales by executives can be routine (diversification, tax planning, liquidity) and do not by themselves indicate a change in outlook; gifts similarly do not imply market sentiment.
• Because the filing only reports these specific changes in beneficial ownership, consult broader insider patterns and company fundamentals before drawing investment conclusions.